1-2 of 2
Huw Roddie, MBChB, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bortezomib-Dexamethasone Alone or Plus Cyclophosphamide or Lenalidomide As Second-Line Treatment for Patients with Multiple Myeloma: Final Results From a Phase 2 Study

Meletios Athanasios Dimopoulos, MD, Meral Beksac, MD, Lotfi Benboubker, MD, PhD, Huw Roddie, MBChB, PhD, Nathalie Allietta, Esther Broer, Catherine Couturier, PharmD, Marie-AndreĢe Mazier, DESS, Ralf Angermund, MD, Thierry Facon, MD
Journal: Blood
Blood (2011) 118 (21): 1861.
https://doi.org/10.1182/blood.V118.21.1861.1861
Published: 2011
Journal Articles

Lenalidomide Enhances Leukaemia Specific T Cell Responses to Dendritic Cell Based Immunotherapy for Myeloid Leukaemias.

Caroline J Duncan, MBBS, MRCP(Ed), Peter R. E. Johnson, MD, Huw Roddie, MBChB, PhD
Journal: Blood
Blood (2008) 112 (11): 1954.
https://doi.org/10.1182/blood.V112.11.1954.1954
Published: 2008